InvestorsHub Logo
Followers 76
Posts 10333
Boards Moderated 0
Alias Born 02/23/2010

Re: None

Monday, 10/18/2021 1:43:03 AM

Monday, October 18, 2021 1:43:03 AM

Post# of 403047
..."Based on information received from the data management and biostatistics vendors, study unblinding, analysis of the unblinded data and release of topline study results for the Brilacidin COVID-19 trial is anticipated to occur in mid-to-late October"



Better not to create false expectations, it can be today or in the next fifteen days,
So much expectation of PR today feeds the detractors in case of not taking place
The PR says it clear, "mid-to-late October"


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News